Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher H Lieu

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Future Oncology (London, England)|May 3, 2023
Podcast article: Biomarker testing in colorectal cancerChristopher H Lieu
Journal of Gastrointestinal Oncology|October 18, 2016
Beyond RAS and BRAF: a target rich disease that is ripe for pickingTyler Friedrich, Stephen Leong, Christopher H Lieu
Cancers|July 29, 2023
The Local Microbiome in Esophageal Cancer and Treatment Response: A Review of Emerging Data and Future DirectionsAbhishek Pandey, Christopher H Lieu, Sunnie S Kim
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Integrating Biomarkers and Targeted Therapy Into Colorectal Cancer ManagementChristopher H Lieu, Ryan B Corcoran, Michael J Overman
Journal of Gastrointestinal Oncology|November 18, 2021
Neoadjuvant treatment of localized pancreatic adenocarcinomaAlexis D Leal, Wells A Messersmith, Christopher H Lieu
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 26, 2023
Early-Onset GI Cancers: Rising Trends, Genetic Risks, Novel Strategies, and Special ConsiderationsEmily Harrold, Alicia Latham, Naveen Pemmaraju, et al.
Cancer Journal (Sudbury, Mass.)|June 25, 2016
Therapeutic Approaches to RAS MutationAaron J Scott, Christopher H Lieu, Wells A Messersmith
Journal of Gastrointestinal Cancer|May 30, 2024
Prolonged Response to Dabrafenib/Trametinib in Grade 3 Metastatic Pancreatic Neuroendocrine Tumor (NET G3) with BRAF V600E MutationBenjamin E Ueberroth, Christopher H Lieu, Robert W Lentz
World Journal of Gastroenterology|May 31, 2022
Current status and future of targeted peptide receptor radionuclide positron emission tomography imaging and therapy of gastroenteropancreatic-neuroendocrine tumorsNeil Grey, Michael Silosky, Christopher H Lieu, et al.
Advances in Cancer Research|June 21, 2021
Early age onset colorectal cancerSwati G Patel, Caitlin C Murphy, Christopher H Lieu, et al.
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Future Oncology (London, England)|May 3, 2023
Podcast article: Biomarker testing in colorectal cancerChristopher H Lieu
Journal of Gastrointestinal Oncology|October 18, 2016
Beyond RAS and BRAF: a target rich disease that is ripe for pickingTyler Friedrich, Stephen Leong, Christopher H Lieu
Cancers|July 29, 2023
The Local Microbiome in Esophageal Cancer and Treatment Response: A Review of Emerging Data and Future DirectionsAbhishek Pandey, Christopher H Lieu, Sunnie S Kim
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Integrating Biomarkers and Targeted Therapy Into Colorectal Cancer ManagementChristopher H Lieu, Ryan B Corcoran, Michael J Overman
Journal of Gastrointestinal Oncology|November 18, 2021
Neoadjuvant treatment of localized pancreatic adenocarcinomaAlexis D Leal, Wells A Messersmith, Christopher H Lieu
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 26, 2023
Early-Onset GI Cancers: Rising Trends, Genetic Risks, Novel Strategies, and Special ConsiderationsEmily Harrold, Alicia Latham, Naveen Pemmaraju, et al.
Cancer Journal (Sudbury, Mass.)|June 25, 2016
Therapeutic Approaches to RAS MutationAaron J Scott, Christopher H Lieu, Wells A Messersmith
Journal of Gastrointestinal Cancer|May 30, 2024
Prolonged Response to Dabrafenib/Trametinib in Grade 3 Metastatic Pancreatic Neuroendocrine Tumor (NET G3) with BRAF V600E MutationBenjamin E Ueberroth, Christopher H Lieu, Robert W Lentz
World Journal of Gastroenterology|May 31, 2022
Current status and future of targeted peptide receptor radionuclide positron emission tomography imaging and therapy of gastroenteropancreatic-neuroendocrine tumorsNeil Grey, Michael Silosky, Christopher H Lieu, et al.
Advances in Cancer Research|June 21, 2021
Early age onset colorectal cancerSwati G Patel, Caitlin C Murphy, Christopher H Lieu, et al.
Pageof 7